PyInvesting

Market research

NC6.AU Nanollose Limited

AU AUD Consumer Cyclical

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
32M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.72

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Nanollose Limited is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

Nanollose Limited's total revenue sank by 66.9% to $2K since the same quarter in the previous year.

Its net income has increased by 25.0% to $-441K since the same quarter in the previous year.

Finally, its free cash flow fell by 28.6% to $-347K since the same quarter in the previous year.

Based on the above factors, Nanollose Limited gets an overall score of 2/5.